Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation

NCT07777744 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2026-08-20

No results posted yet for this study

Summary

The investigators aim to characterize patients presenting with a severe ventricular tachycardia (VT) and premature ventricular complex (PVC)-ablation-related complication including patient characteristics, procedural details and subsequent management of the complication by gathering existing patient-level data.

Conditions

  • Ventricular Tachycardia (VT)
  • Premature Ventricular Complexes

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Michael Kühne, Prof. Dr. med. · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • United States
  • Austria
  • Canada
  • China
  • Croatia
  • France
  • Germany
  • Greece
  • Israel
  • Italy
  • Singapore
  • Slovenia
  • Spain
  • Switzerland
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07777744 on ClinicalTrials.gov